This inventor holds 1 USPTO granted patent. Top assignee: Cilag International Gmbh. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Rolf Hänseler: Innovator in Iron(III)gluconate Complex Production
Introduction
Rolf Hänseler is a notable inventor based in Hallau, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of methods for producing iron(III)gluconate complexes. His innovative approach has implications for pharmaceutical applications, especially in treating anemic conditions.
Latest Patents
Hänseler holds a patent for a method of making iron(III)gluconate complex. This method involves several steps, including mixing a water-soluble iron(III) salt with gluconic acid or its salts, along with an alkali hydroxide or carbonate. The process ensures that the reaction mixture maintains a pH value between 7.0 and 12. Following this, the mixture is heated to form the iron(III)gluconate complex, which is then precipitated using an organic solvent. This patent highlights his innovative approach to creating a valuable compound for medical use.
Career Highlights
Rolf Hänseler is associated with Cilag International GmbH, where he continues to work on advancements in pharmaceutical chemistry. His expertise and dedication to innovation have positioned him as a key figure in his field. With 1 patent to his name, he exemplifies the spirit of invention that drives progress in science and medicine.
Collaborations
Hänseler collaborates with Michael Justus, contributing to the development of new pharmaceutical solutions. Their partnership reflects a commitment to advancing healthcare through innovative chemistry.
Conclusion
Rolf Hänseler is a distinguished inventor whose work on iron(III)gluconate complexes has the potential to impact the treatment of anemia. His contributions to the field of chemistry are noteworthy and demonstrate the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
